HomeCompareGRPOF vs PFE

GRPOF vs PFE: Dividend Comparison 2026

GRPOF yields 263.82% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GRPOF wins by $649.51M in total portfolio value
10 years
GRPOF
GRPOF
● Live price
263.82%
Share price
$0.76
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$649.56M
Annual income
$372,102,534.33
Full GRPOF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — GRPOF vs PFE

📍 GRPOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGRPOFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GRPOF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GRPOF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GRPOF
Annual income on $10K today (after 15% tax)
$22,424.48/yr
After 10yr DRIP, annual income (after tax)
$316,287,154.18/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, GRPOF beats the other by $316,264,834.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GRPOF + PFE for your $10,000?

GRPOF: 50%PFE: 50%
100% PFE50/50100% GRPOF
Portfolio after 10yr
$324.80M
Annual income
$186,064,396.53/yr
Blended yield
57.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

GRPOF
No analyst data
Altman Z
1.5
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GRPOF buys
0
PFE buys
0
No recent congressional trades found for GRPOF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGRPOFPFE
Forward yield263.82%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$649.56M$49.6K
Annual income after 10y$372,102,534.33$26,258.71
Total dividends collected$620.51M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GRPOF vs PFE ($10,000, DRIP)

YearGRPOF PortfolioGRPOF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$37,082$26,381.74$9,153$693.39+$27.9KGRPOF
2$131,106$91,428.14$8,593$849.25+$122.5KGRPOF
3$442,387$302,104.50$8,336$1,066.78+$434.1KGRPOF
4$1,426,052$952,697.46$8,437$1,384.80+$1.42MGRPOF
5$4,396,020$2,870,144.59$9,013$1,875.40+$4.39MGRPOF
6$12,972,576$8,268,834.55$10,306$2,680.72+$12.96MGRPOF
7$36,685,499$22,804,841.95$12,820$4,101.38+$36.67MGRPOF
8$99,524,911$60,271,427.98$17,673$6,826.70+$99.51MGRPOF
9$259,306,336$152,814,680.40$27,543$12,591.86+$259.28MGRPOF
10$649,560,314$372,102,534.33$49,560$26,258.71+$649.51MGRPOF

GRPOF vs PFE: Complete Analysis 2026

GRPOFStock

Grupo Traxión, S.A.B. de C.V. operates as a transportation and logistics company in Mexico. It operates through three segments: Mobility of Cargo, Logistics and Technology, and Mobility of Personnel. The company offers dry and refrigerated box, hopper, platform, midrange units, intermodal and multimodal, import and export, national distribution, cross border, port, cross dock, and door-to-door freight services; logistics integration services, such as land management, control tower, networks consultancy, eCommerce, consolidated, specialized, door-to-door, land, air, and maritime services; and storage services, including dedicated warehousing, shared warehouses, platform crossings, inventory management, product unloading and loading, finishing and raw materials, exports shipping, inverse logistics, automated and aleatory systems, and collection by radiofrequency and/or voice, as well as copacking and production for exports, such as labeling, product assembling, promotional materials, thermal-forming, and sealing. It also provides warehouse management, transport management, and control tower systems; parcel and courier, collection and home delivery, documents return, parcel tracking, domestic and cross-border shipments, guarantees and shipping insurance, and packing and packaging services; and personnel and student transportation services. In addition, the company offers special services, such as rental of trucks and vans for events; national and international moving services; intermediation services; advertising solutions; technological mobility solutions comprising logistics focused digital platforms and mobile applications. The company was formerly known as Fondo de Transporte México, S.A.P.I. de C.V. and changed its name to Grupo Traxión, S.A.B. de C.V. in September 2017. Grupo Traxión, S.A.B. de C.V. was incorporated in 2011 and is based in Mexico City, Mexico.

Full GRPOF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this GRPOF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GRPOF vs SCHDGRPOF vs JEPIGRPOF vs OGRPOF vs KOGRPOF vs MAINGRPOF vs JNJGRPOF vs MRKGRPOF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.